Specific immunotherapy of cancer using a live recombinant...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 39/02 (2006.01)

Patent

CA 2204666

Vaccines containing recombinant Listeria monocytogenes capable of expressing tumor specific antigens are provided. These vaccines, when administered to a host, are capable of inducing an immune response to the tumor specific antigen. Methods of using these vaccines in the suppression tumor formation are also provided.

L'invention a pour objet des vaccins contenant des Listeria monocytogenes de recombinaison pouvant exprimer des antigènes spécifiques contre les tumeurs. Ces vaccins, une fois administrés à un hôte, permettent d'induire une réponse immunitaire par rapport à l'antigène spécifique contre les tumeurs. L'invention traite également de procédés d'utilisation de ces vaccins pour supprimer la formation des tumeurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Specific immunotherapy of cancer using a live recombinant... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Specific immunotherapy of cancer using a live recombinant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific immunotherapy of cancer using a live recombinant... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1561626

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.